Search

Two copper(II) complexes, [Cu2(L1)2]·2H2O (1) and [Cu3(L1)2(NCS)2] (2), and two nickel(II) complexes, [NiL2(NCS)] (3) and [Ni(L2)2(NCS)]·CH3OH (4), were prepared from the fluorine substituted Schiff bases N,N'-bis(4-fluorosalicylidene)-1,2-diaminopropane (H2L1) and 4-fluoro-2-[(2-isopropylaminoethylimino)methyl]phenol (HL2), respectively. The compounds were characterized by physico-chemical methods. Structures of the complexes were further confirmed by single crystal X-ray diffraction. The Cu ions in 1 are square pyramidal, and in 2 are square planar and octahedral. The Ni ion in 3 is square planar, and in 4 is octahedral. All the complexes have effective Jack bean urease inhibitory activities. Complex 1 has the most effective activity, with an IC50 value of 2.1 ± 1.3 μmol L−1. [ABSTRACT FROM AUTHOR]

Urease catalyzes the decomposition of urea into ammonia, which has harmful effects on both human health and fertile soil. Aiming at exploring novel urease inhibitors, a series of hydrazone compounds and their CoIII, CuII, NiII, and ZnII complexes were prepared from 4-methoxy-N'-(pyridin-2-ylmethylene)benzohydrazide (HL). They are [CoClL(NCS)] (1), [CoL2]·Cl·CH3OH·H2O (2), [CuL(NCNCN)]n·nCH3OH (3), [NiL(HL)]·ClO4·CH3OH (4) and [ZnClL(OH2)]·CH3OH (5). The compounds were characterized by physico-chemical methods. Structures of the complexes were further confirmed by single crystal X-ray diffraction. The metal ions in 1, 3, and 5 display square pyramidal coordination and 2 and 4 display octahedral coordination. The inhibitory effects of the compounds on Jack bean urease were evaluated. The results showed that 3 has effective urease inhibitory activity, with IC50 value of (7.3 ± 1.0) μmol L−1. [ABSTRACT FROM AUTHOR]

Five new Ni(II) Schiff base complexes [NiLx(Solv)2] denoted by NiLx,x = 1–5, were synthesized and characterized. The Schiff base ligands were synthesized from the condensation of 5-bromo-2-hydroxy-3-nitrobenzaldehyde with different aliphatic and aromatic diamines. The X-ray crystal structure of NiL3was determined. The ligands and complexes were tested as antibacterial agents against two gram(+) and two gram(−) human pathogenic bacteria. The complexes showed moderate antibacterial activity against both gram type bacteria. The new Ni(II) complexes showed enhanced antibacterial activity compared to the previously reported Cu(II) complexes of the same ligands. [ABSTRACT FROM PUBLISHER]